Literature DB >> 8823385

Quantification of interleukin-6 mRNA in wallerian degeneration by competitive reverse transcription polymerase chain reaction.

O Bourde1, R Kiefer, K V Toyka, H P Hartung.   

Abstract

Following peripheral nerve injury, cytokines might be critically involved in regulating the cellular response within the lesioned nerve but are frequently difficult to measure due to their low abundancy. Competitive quantitative RT-PCR assays are potentially useful in quantifying cytokine mRNAs in small tissue samples but frequently do not fulfill the theoretical demands on proportional amplification of natural and standard sequences. Using this technique, we constructed standard curves for rat interleukin (IL)-6 mRNA with strictly proportional slopes and shifts when varying natural and standard RNA concentrations. A strong and transient increase in IL-6 mRNA was found in both nerve stumps 12 h after rat sciatic nerve transection, with low expression already in uninjured rat sciatic nerves. IL-6 might be involved in regulating the cellular response to peripheral nerve injury, and standard curves obtained by independent variation of standard and natural RNA are helpful in detecting and controlling experimental variables and pitfalls in competitive RT-PCR assays, thus increasing their reliability and reproducibility.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8823385     DOI: 10.1016/0165-5728(96)00087-2

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  13 in total

1.  Nature of the retrograde signal from injured nerves that induces interleukin-6 mRNA in neurons.

Authors:  P G Murphy; L S Borthwick; R S Johnston; G Kuchel; P M Richardson
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

Review 2.  Potential novel uses of thalidomide: focus on palliative care.

Authors:  V Peuckmann; M Fisch; E Bruera
Journal:  Drugs       Date:  2000-08       Impact factor: 9.546

3.  Sensory impairments and delayed regeneration of sensory axons in interleukin-6-deficient mice.

Authors:  J Zhong; I D Dietzel; P Wahle; M Kopf; R Heumann
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

4.  Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies.

Authors:  R Kiefer; F Dangond; M Mueller; K V Toyka; D A Hafler; H P Hartung
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

5.  Increase in inflammatory cytokines in median nerves in a rat model of repetitive motion injury.

Authors:  Talal Al-Shatti; Ann E Barr; Fayez F Safadi; Mamta Amin; Mary F Barbe
Journal:  J Neuroimmunol       Date:  2005-10       Impact factor: 3.478

6.  Wallerian degeneration in ICAM-1-deficient mice.

Authors:  V I Vougioukas; S Roeske; U Michel; W Brück
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

7.  Spinal activity of interleukin 6 mediates myelin basic protein-induced allodynia.

Authors:  Justin S Ko; Kelly A Eddinger; Mila Angert; Andrei V Chernov; Jennifer Dolkas; Alex Y Strongin; Tony L Yaksh; Veronica I Shubayev
Journal:  Brain Behav Immun       Date:  2016-03-09       Impact factor: 7.217

8.  Differential expression and potential role of SOCS1 and SOCS3 in Wallerian degeneration in injured peripheral nerve.

Authors:  Elizabeth I Girolami; Delphine Bouhy; Michael Haber; Howard Johnson; Samuel David
Journal:  Exp Neurol       Date:  2009-07-02       Impact factor: 5.330

9.  Frataxin deficiency induces Schwann cell inflammation and death.

Authors:  Chunye Lu; Robert Schoenfeld; Yuxi Shan; Hsing-Jo Tsai; Bruce Hammock; Gino Cortopassi
Journal:  Biochim Biophys Acta       Date:  2009-08-10

10.  Bilateral elevation of interleukin-6 protein and mRNA in both lumbar and cervical dorsal root ganglia following unilateral chronic compression injury of the sciatic nerve.

Authors:  Petr Dubový; Václav Brázda; Ilona Klusáková; Ivana Hradilová-Svíženská
Journal:  J Neuroinflammation       Date:  2013-05-01       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.